• The mass vaccination of dogs against rabies is the most rational strategy for interrupting the natural transmission of rabies. Knowledge of the virusneutralizing antibody (VNA) level against the rabies virus (RABV) is required to evaluate herd immunity of dogs in mass vaccination campaigns.
Summary
The mass vaccination of dogs against rabies is a highly rational strategy for interrupting the natural transmission of urban rabies. According to the World Organization for Animal Health (OIE) and the World Health Organization (WHO), the immunization of at least 70% of the total dog population minimizes the risk of endemic rabies. Knowledge of the virus-neutralizing antibody (VNA) level against the rabies virus (RABV) is required to evaluate protective immunity and vaccine coverage of dogs in the field. The rapid focus fluorescent inhibition test (RFFIT) and the fluorescent antibody virus neutralization (FAVN) test are recommended by OIE and WHO to determine the VNA levels in serum. However, these tests are cell culture based and require the use of live viruses and specialized equipment. The rapid neutralizing antibody test (RAPINA) is a novel, immunochromatographic test that uses inactivated virus to estimate the VNA level qualitatively. It is a simple, rapid and inexpensive, although indirect, assay for the detection of VNA levels. The RAPINA has shown good positive and negative predictive values and a high concordance with the RFFIT results. In this study, we compared the performance of the two tests for evaluating the vaccination status of dogs in the Philippines, Thailand and Japan. A total of 1135 dog
Introduction
Rabies is an acute and fatal encephalitis that is caused by the rabies virus (RABV). Rabies is a typical zoonotic disease that, globally, accounts for more than 55 000 deaths per year, with 56% of the deaths estimated to occur in Asia and 44% in Africa; it is a neglected infectious disease that affects mostly poor and vulnerable populations (Bourhy et al., 2010) (WHO, 2013) (Warrell and Warrell, 2004) . Although transmission is generally caused by urban dogs, the virus has not been eradicated in most countries and rabies remains endemic worldwide (WHO, 2013) . The mass vaccination of dogs against RABV is a highly rational strategy for interrupting the natural transmission cycle of urban rabies. According to the World Organization for Animal Health (OIE) and the World Health Organization (WHO), the immunization of at least 70% of the total dog population minimizes the risk of endemic rabies (WHO, 2013) (Knobel et al., 2005) . Knowledge of the level of herd immunity is essential to maintain the effect of a mass vaccination programme. Neutralizing antibodies are considered a key component of the adaptive immune response against the rabies virus ( Moore and Hanlon, 2010) . Monitoring of the virus-neutralizing antibody (VNA) level against RABV is a crucial tool in securing the safe transport of animals from endemic to non-endemic countries (Wasniewski et al., 2014) . In addition, rabies seroepidemiology is used mainly to determine the response to vaccination, in either domestic or wild animal populations (OIE, 2012) . As recommended by OIE and WHO, a titre of 0.5 IU/mL of antirabies binding antibodies is recognized as the minimum level for protection against the disease (WHO, 2013) .
Currently, the OIE and WHO recommend the use of the rapid focus fluorescent inhibition test (RFFIT) and the fluorescent antibody virus neutralization (FAVN) test to determine the serum VNA titres (WHO, 2013) (OIE, 2012) (Cliquet et al., 1998) . However, these tests are cell culture based and require the use of live viruses, biosafety considerations and specialized equipment. As such, rabies laboratories in resource-limited areas often cannot perform the test. As an alternative to seroneutralization, the enzyme-linked immunosorbent assay (ELISA), which uses purified rabies glycoprotein (G), has been reported to be useful in determining the anti-G antibody levels in serum when the RFFIT and FAVN test are not available (WHO, 2013) (Cliquet et al., 2004) (Wasniewski et al., 2012) . Several ELISA kits have been developed and yield promising results compared with the RFFIT and FAVN test (Wasniewski et al., 2014) (Cliquet et al., 2004 ) (De Benedictis et al., 2012 (Servat et al., 2006) . However, the agreement between the ELISA and virus neutralization test was controversial, sometimes poor due to haemolysis, and freeze-thawing may affect the performance of the ELISA (Servat et al., 2008) (Knoop et al., 2010) (Bedekovic et al., 2013) .
The RAPINA (rapid neutralizing antibody test) was developed to eliminate the requirement for live viruses by estimating the VNA titre using inactivated virus. This method estimates VNA titres through an immunochromatographic method that measures the competitive binding of the inactivated virus with a virus-neutralizing monoclonal antibody. This method does not involve actual virus neutralization; it is an indirect measurement of RABV G protein-specific antibodies. It is a simple, rapid and inexpensive test. RAPINA allows an indirect detection of the RABV G protein-specific antibodies by detecting virus particles that are unbound to the neutralizing antibody using a monoclonal antibody against RABV (Shiota et al., 2009 ). An improvement allows the RAPINA to provide an estimate of the corresponding level of VNA both qualitatively and semiquantitatively using two different neutralizing monoclonal antibodies against the rabies virus G protein; each monoclonal antibody recognizes a different epitope (Nishizono et al., 2012) . This improvement increased the positive predictive value of the RAPINA from 90% to 99% and the concordance with the RFFIT is greater than 0.95 (Nishizono, 2014) .
In resource-limited countries or geographical areas, a simple, rapid and inexpensive serological method is necessary for the detection of VNA levels. To evaluate the use of the RAPINA as an alternative to the RFFIT and FAVN test, we assessed the performance of the RAPINA by comparing the test results from three different countries (the Philippines, Thailand and Japan) to the results from the RFFIT. The performance of the tests was evaluated using the sensitivity, specificity and positive and negative predictive values.
Materials and Methods

Sample collection
The collection of dog sera in the Philippines, Thailand and Japan A total of 305 sera were collected during the Knowledge, Attitude and Practices (KAP) survey of the Bohol Rabies Prevention and Elimination Project (BRPEP) in the province of Bohol, the Philippines, between 2010 and 2011 (Lapiz et al., 2012; Davlin et al., 2014) . Thirty clusters were selected from a sampling frame of 1109 districts following probability sampling proportionate to size. Ten households per cluster were sampled for a total sample size of 300. The first household was chosen randomly, and the subsequent ones were selected based on proximity to the first household. Each household was interviewed regardless of dog ownership using a structured questionnaire. Information on each dog in the household, including blood collection date, vaccination status, age and sex, was gathered for the dog ecology study using a separate set of questionnaires.
In Thailand, 58 samples were collected from dogs that were brought for a regular health check to animal hospitals in the cities of Bangkok and Chiang Mai. Information on age and vaccination status was collected for each dog. The vaccine used for dog vaccination in both the Philippines and Thailand was Rabisin â (Merial, Philippines).
In Japan, 772 sera were collected from 30 animal hospitals (28 in Oita Prefecture and two in Tokyo) between May 2010 and November 2011 (Watanabe et al., 2013) . Verbal consent was obtained from the owner of each dog after a detailed explanation of the testing procedure. The date of birth, number of vaccinations against rabies, number of days since the last vaccination and the sample collection date were recorded for each dog. The dog vaccinations in Japan were performed using six different commercially available, widely used, tissue-cultured rabies vaccines for animals; each vaccine was derived from the RC-HL strain, which originated from the Nishigahara strain after numerous passages (Ito et al., 1994) . All sampling in this study was not performed without any bias.
Sera separation
After collection, the blood samples were stored at room temperature for 15 min, and the serum was separated by centrifugation at 2000 g at 4°C for 10 min. The serum samples were stored at À20°C and sent to the laboratory for testing by the RAPINA and RFFIT. The frozen samples were thawed, and the serum complement was inactivated by heating at 56°C for 30 min before the RFFIT and RAPINA analysis.
Ethical considerations
All animal-related manipulations (blood sampling) were performed by veterinarians at the time of visiting the animal hospital or the regional registration site and were conducted according to Japanese (http://www.scj.go.jp/ja/info/ kohyo/pdf/kohyo-20-k16-2e.pdf) and international (http:// www.cioms.ch/images/stories/CIOMS/IGP2012.pdf) guidelines. Verbal consent was obtained from the owner of each dog. This study was approved by the Ethics Committee of Oita University (M010003).
Determination of the VNA levels by RFFIT
The VNA levels were determined using the RFFIT (Smith et al., 1973 ) with a slight modification as described by Khawplod et al., 2005 . The RFFIT was independently performed in each laboratory. First, serial dilutions of heatinactivated serum samples were incubated in a 96-well plate with the rabies challenge virus standard strain CVS-11 (100 TCID 50 /well) at 37°C for 90 min. Then, BHK-21 cells were added to each well, and the plates were incubated in a 5% CO 2 incubator at 37°C for 18 h. Finally, the culture medium was discarded, and the cells were fixed with 90% acetone, stained with fluorescein isothiocyanate (FITC)-conjugated antirabies N monoclonal antibody (Fujirebio Diagnostics Inc., Malvern, PA) at 37°C for 45 min and observed under a fluorescence microscope (magnification 1009). The VNA levels were calculated by comparison with the WHO standard serum [RAI: Anti-rabies Immunoglobulin, human, National Institute for Biological Standards & Control (NIBSC)]. According to the OIE, VNA levels of ≥0.5 IU/mL are adequate for protection against rabies in animals and this value is also recommended for dogs by the OIE (OIE, 2012) .
RAPINA test
Heat-inactivated, undiluted serum samples were mixed with the same amount of 0.01% formalin-inactivated CVS-11 virus solution (0.03 mg/mL corresponding with approximately 5.0 9 10 7 FFU/mL) and incubated at 37°C for 30 min. A total of 100 lL of the mixture was transferred into the sample hole of the RAPINA kit (Adotec Co., Ltd., Usa, Oita Japan) and allowed to react for 15 min at room temperature. If a band was visible in the control and the test lines, the result of the RAPINA was considered negative, which was interpreted as the corresponding level of VNA <0.5 IU/mL as measured by the viral neutralization test (RFFIT or FAVN test) . If a band was visible only in the control line, the RAPINA value was considered positive, indicating a corresponding level of VNA ≥0.5 IU/mL. In cases where no band was visible at the control line, the test was considered invalid (Shiota et al., 2009) (Nishizono et al., 2012) . The examiners were not aware of the vaccination status of the submitted samples prior to the RAPINA or RFFIT. Representative positive (a), negative (b) and invalid (c) data collected from the RAPINA are shown in Fig. 1 .
Data analysis
In each country, the sensitivity, specificity and positive and negative predictive values were computed. A chi-square test was used to compare the results of the RAPINA and RFFIT among the three countries. The concordance was determined with the kappa statistic as follows: kappa (j) = (observed agreementÀexpected agreement)/1Àexpected agreement. Kappa values range between 0 (not concordance) and 1 (full concordance) and represent the degree of concordance excluding random events. A j value >0.81 is considered almost perfect concordance (Nishizono et al., 2012) .
Results
A total of 1135 dog sera were collected from three countries: the Philippines, Thailand and Japan. During the BRPEP survey in the Philippines, 305 dog sera were collected from Bohol Island: 178 (58.4%) from dogs that had been vaccinated, 115 (37.7%) from dogs that had not been vaccinated, and 12 (3.9%) from animals with an unknown vaccination status. There were more males (n = 149, 48.9%) than females (n = 116, 38%), and the remainder of the dogs were of an unknown sex. The mean age of the dogs was 2.42 AE 2.66 years (ranging from 3 months to 18 years), and 13.8% (n = 43) of the dogs were of an unknown age. In Thailand, 58 dog sera were collected from the veterinary hospitals of Bangkok City (n = 45) and Chiang Mai City (n = 13). The mean age of dogs was 1.67 AE 2.43 years (ranging from 3 months to 7 years). The vaccination status was known only for the samples collected from Chiang Mai. In Japan, 772 dog serum samples were collected from 30 animal hospitals: 685 from vaccinated and 31 from unvaccinated dogs. The remainder of the dogs had an unknown vaccination status. The average age of the dogs was 7.22 AE 4.26 years (ranging between 5 days and 19 years). There were more males (334) than females (314), and the sex of the remainder of the dogs was unknown. Table 1 summarizes the test results for all sera obtained from the three countries as determined by the 'gold standard' RFFIT and the RAPINA. In the Philippines, 156 samples (51.15%) tested positive in the RFFIT, of which 148 were positive in the RAPINA. A total of 149 samples were negative in the RFFIT, of which 148 were also negative in the RAPINA. The sensitivity of the RAPINA compared with the RFFIT was 94.9% (148/156), and the specificity was 99.3% (148/149). Of the 58 samples from Thailand, the VNA titre in one serum sample could not be determined by the RFFIT because of its cytotoxic effect on the BHK-21 cells, which were used as indicator cells. Therefore, this sample was diluted 32 times in phosphate-buffered saline for the RFFIT. However, the RAPINA was suitable to determine the presence of RABV G protein-specific antibodies even in the undiluted serum of this sample. The remaining 57 samples were used undiluted for the RFFIT and the RAPINA. A total of 25 of the 27 samples that tested positive in the RFFIT also tested positive in the RAPINA (sensitivity: 92.6%), and the specificity was 96.6% (29/30). An evaluation of the 772 samples obtained from veterinary hospitals in Japan indicated a sensitivity of 97.6% (659/ 675) and a specificity of 91.8% (89/97).
The positive and negative predictive values, respectively, of the RAPINA were 99.3% and 94.8% in the Philippines, 96.2% and 93.5% in Thailand, 98.8% and 84.2% in Japan. The concordance between the RAPINA and RFFIT was 0.97 in the Philippines, 0.946 in Thailand and 0.969 in Japan, and the results were significantly concordant (P = 0.0001) in all three countries. A comparison of the results obtained in the three laboratories revealed that the RAPINA results were highly homologous and reproducible among the three laboratories, indicating a high performance of the test. As shown in Fig. 2 , several dog samples having a high VNA titre (≥0.5 IU/mL, cross marks) in the RFFIT yielded false-negative results in the RAPINA. In particular, four samples #1-4 (Fig. 2 , cross marks bound with asterisk) collected from dogs in Japan showed an adequately high VNA titre determined by RFFIT, and these dogs had received more than five times the annual mandatory vaccination. Samples #1 (RFFIT VNA = 14.68 IU/mL), #2 (21.7 IU/mL), #3 (25.79 IU/mL) and #4 (33.33 IU/mL) each had only a faint band in the test line zone of the RAPINA. We repeated the assay using a RAPINA kit from a different batch and found similar, negative results, indicating that the samples did not contain RABV G protein-specific antibodies.
Of the 305 samples from the Philippines, 33 samples initially showed discordance between the RAPINA and RFFIT results. However, the test was initially performed without heat inactivation processing of the serum. The RAPINA and RFFIT were repeated using the original serum in the laboratory in the Philippines. After the retest, 24 of the 33 samples yielded results that were consistent with the RFFIT results. However, nine samples still showed discordant results ( Table 2 ). The VNA titre of one sample (No. 1) was 0.42 IU/mL while the RAPINA was positive. The VNA titres of the remaining eight samples (No. 2-9) ranged from 0.55 to 1.68 IU/mL, but the results of the RAPINA were all negative. Therefore, we concluded that these cases were false positive and false negatives, respectively. These results indicated that complete heat inactivation of the serum sample prior to testing is necessary for accurate evaluation of the level of corresponding VNA with the RAPINA, and samples with borderline VNA titres (VNA = 0.3-0.7, grey zone in Fig. 2 ) are difficult to discriminate. The chi-square test showed that the RAPINA and RFFIT results in the three countries were not significantly different (P = 0.0001).
Discussion
Recently, several alternatives to the RFFIT and FAVN test have been developed to estimate VNA titres (Shiota et al., 2009) (Ma et al., 2012) (Wang et al., 2010) (Batista et al., 2011) (Madhusudana et al., 2014) . As one of the alternative methods, we recently developed the RAPINA, which is an easy, rapid and inexpensive immunochromatographybased competitive test using formalin-fixed virus particles for the detection of RABV G protein-specific antibodies (Shiota et al., 2009) (Nishizono et al., 2012) (Nishizono, 2014) . To determine the performance of the test in comparison with RFFIT in different settings, the kit was distributed to rabies laboratories in Japan, Thailand and Sri Lanka for preliminary evaluation. Similar to our RAPINA, Wang et al. developed an immunochromatographic test strip (ICTS) that was constructed by coating colloidal gold-RABV G antigen onto the test line to directly detect antibodies against RABV in serum (Wang et al., 2010) . In the ICTS, the appearance of two bands on the strip indicates the presence of the neutralizing antibody (≥0.5 IU/mL) in the sample. In contrast, the RAPINA can indirectly detect rabies antibody specific for G protein epitopes using serum pre-incubated with an inactivated rabies virus (CVS-11) through identification of only one band on the control line, indicating the presence of the antibody specific for G protein epitopes (≥0.5 IU/mL). The rapid and easy estimation of VNA levels against RABV in the field is very important for an early and effective response to rabies in both the animal and human health sectors. The RAPINA is considered an alternative test to estimate the serum VNA titre after rabies vaccination. This test could be used to monitor the success of mass animal vaccination campaigns in an easy, rapid and inexpensive manner in rabies-free countries as well as in potentially endemic countries. The user-friendly characteristics of the RAPINA are promising not only for the promotion of effective mass animal vaccination campaigns but also for a screening of vaccination response in dogs.
Consistent with our previous studies (Shiota et al., 2009) (Nishizono et al., 2012) , we found significant concordance between the RAPINA and RFFIT results in the Philippines, Thailand and Japan. In terms of the negative predictive value, there remains room for improvement. Several dog samples that tested negative in the RAPINA showed ≥5.0 IU/mL in the RFFIT. The reason for this discrepancy has been discussed in a previous report (Nishizono et al., 2012) ; although these samples possess neutralizing antibodies, they do not possess the neutralizing monoclonal antibody (recognizing two different epitopes of the RABV G protein) used on the RAPINA chromatography strip. In contrast, the positive predictive value was quite high. Another limitation of this study was the low sample size, especially in Thailand, which resulted in low reliability of diagnostic accuracy measures such as the sensitivity, specificity and positive and negative predictive values (Gilchrist, 2009) .
Some dog serum samples exhibited cytotoxicity against BHK-21 cells, which are used in neutralization tests (Wasniewski and Cliquet, 2012) (Smith et al., 1973) . Because such poor quality samples might cause false test results, these serum samples must be diluted before measuring the VNA level, resulting in an increased risk for false negatives (Bedekovic et al., 2013) . However, while a low titre of VNA might not be detected by the RFFIT or FAVN, it could be estimated using the RAPINA. Unlike an ELISA, the RAPINA can predict the VNA level in the serum of any type of animal (except mice) because it does not require a secondary antibody. Therefore, the RAPINA might be useful for the evaluation of seroprevalence in wildlife, including foxes or bats. In order to evaluate viral antigen directly binding to monoclonal antibody on the RAPINA test strip, any inhibitors including complements should not be included in the test serum. It is critically important that the sera or plasma samples are heat-inactivated prior to being tested with the RAPINA; the detection power was markedly reduced without heat inactivation. However, the test can be used without special experimental expertise or precautions. Therefore, we believe that the RAPINA will be a recommended alternative to the standard RFFIT and FAVN test, and we expect that it will be one of the key factors facilitating rabies control in epidemic areas. To be approved by international authorities, the RAPINA should be strictly evaluated from various viewpoints; inter-and intralaboratory evaluation in a blind fashion using identical serum samples in different countries will be needed.
